Orthofix's M6-C artificial disc is being evaluated for contiguous two-level symptomatic cervical radiculopathy, according to an Aug. 2 news release.
Spinal Tech
From SeaSpine's purchase of a highly touted imaging system to a multibillion dollar deal that bolstered Stryker's extremities portfolio, here are eight acquisitions of $100 million or more made in the last eight months:
The spine market continued to stabilize in the second quarter as NuVasive reported a 44.8 percent increase in second-quarter net sales compared to the same period last year.
NuVasive's Pulse platform for spine surgery received FDA 510(k) approval, and it is now available for sale.
Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.
Advertisement
Medical device company MirRus raised $65 million in a round of funding for its Rhenium-based spine devices and heart disease treatment development, the company said July 27.
Spine-facing medical technology company Carlsmed is collaborating with the International Spine Study Group Foundation to collect surgical data on personalized interbody devices.
NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, and clinical evaluations of its Pulse spine system got underway in Europe.
Stryker plans to hone in on smaller mergers and acquisitions as part of its strategy for short-term growth, according to CEO Kevin Lobo.
Degenerative disc disease patients who underwent total disc replacement with the ActivL Artificial Disc had better outcomes than patients who received the ProDisc-L, according to a study by Aesculap Implant Systems.